Form 4: Aveanna Healthcare Holdings Director Sells Shares Under 10b5-1 Plan

Robert M. Williams Jr., a director of Aveanna Healthcare Holdings, reported the sale of common stock indirectly through affiliated entities under a pre-arranged 10b5-1 trading plan.

Summary

• Robert M. Williams Jr., a director of Aveanna Healthcare Holdings, reported sales of common stock on April 1, 2025, and April 2, 2025.
• The sales were executed indirectly through several entities including J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, JHW Iliad Holdings LLC, PSA Iliad Holdings LLC, and JHW Iliad Holdings II LLC.
• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on December 13, 2024.
• The price per share for these sales was $5.63.
• A total of 3,610 shares were sold on April 1, 2025, and 8,166 shares were sold on April 2, 2025, by J.H. Whitney VII, L.P.
• PSA Healthcare Investment Holding LLC sold 1,803 shares on April 1, 2025, and 4,080 shares on April 2, 2025.
• JHW Iliad Holdings LLC sold 559 shares on April 1, 2025, and 1,356 shares on April 2, 2025.
• PSA Iliad Holdings LLC sold 167 shares on April 1, 2025, and 378 shares on April 2, 2025.
• JHW Iliad Holdings II LLC sold 63 shares on April 1, 2025, and 142 shares on April 2, 2025.
• Following these transactions, the reporting person continues to indirectly hold a significant number of shares through these entities.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock sales by a director through affiliated entities under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider transactions.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. The use of a 10b5-1 trading plan suggests that these sales were pre-planned and intended to avoid any concerns about trading on inside information.

Stakeholder Impact

• The stock sales by a director may be perceived neutrally or slightly negatively by shareholders, depending on their interpretation of the insider's actions.
• The impact on other stakeholders (employees, customers, suppliers, creditors) is likely to be minimal, as these transactions do not directly affect the company's operations.

Key Dates

Keywords

Form 4, Aveanna Healthcare Holdings, AVAH, Robert M. Williams Jr., J.H. Whitney, 10b5-1 trading plan, insider trading, stock sale